Clinical study on prevention and treatment of perioperative myocardial injury and cardiac function by Xuemaitong II granule
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2021 |
|---|---|
| Erschienen: |
2021 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:112 |
|---|---|
| Enthalten in: |
Minerva medica - 112(2021), 5 vom: 12. Okt., Seite 663-664 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Li, Qihua [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
Creatine Kinase, MB Form |
|---|
| Anmerkungen: |
Date Completed 03.12.2021 Date Revised 14.12.2021 published: Print-Electronic Citation Status MEDLINE |
|---|
| doi: |
10.23736/S0026-4806.20.06480-0 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM311176801 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM311176801 | ||
| 003 | DE-627 | ||
| 005 | 20231225141710.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231225s2021 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.23736/S0026-4806.20.06480-0 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1037.xml |
| 035 | |a (DE-627)NLM311176801 | ||
| 035 | |a (NLM)32538586 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Li, Qihua |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Clinical study on prevention and treatment of perioperative myocardial injury and cardiac function by Xuemaitong II granule |
| 264 | 1 | |c 2021 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 03.12.2021 | ||
| 500 | |a Date Revised 14.12.2021 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a Citation Status MEDLINE | ||
| 650 | 4 | |a Letter | |
| 650 | 4 | |a Randomized Controlled Trial | |
| 650 | 7 | |a Drugs, Chinese Herbal |2 NLM | |
| 650 | 7 | |a Saponins |2 NLM | |
| 650 | 7 | |a Troponin I |2 NLM | |
| 650 | 7 | |a xuesetong |2 NLM | |
| 650 | 7 | |a Creatine Kinase, MB Form |2 NLM | |
| 650 | 7 | |a EC 2.7.3.2 |2 NLM | |
| 700 | 1 | |a Luo, Libo |e verfasserin |4 aut | |
| 700 | 1 | |a Ji, Haigang |e verfasserin |4 aut | |
| 700 | 1 | |a Yin, Jianfeng |e verfasserin |4 aut | |
| 700 | 1 | |a Liu, Junya |e verfasserin |4 aut | |
| 700 | 1 | |a Xu, Ji |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Minerva medica |d 1945 |g 112(2021), 5 vom: 12. Okt., Seite 663-664 |w (DE-627)NLM000053686 |x 1827-1669 |7 nnns |
| 773 | 1 | 8 | |g volume:112 |g year:2021 |g number:5 |g day:12 |g month:10 |g pages:663-664 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.23736/S0026-4806.20.06480-0 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 112 |j 2021 |e 5 |b 12 |c 10 |h 663-664 | ||